Truist on AdaptHealth (AHCO): 'Nice Strategic Move As Diabetes Divestiture Announced'

July 21, 2026 8:07 AM

Truist Securities analyst David MacDonald reiterated a Buy rating and $14.00 price target on AdaptHealth (NASDAQ: AHCO).The analyst commented: "Nice ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found